Exploiting RNA-Polymerase Fitness Costs in Rifampicin-Resistant Mycobacterium tuberculosis : A Real-World Genotype–Phenotype Mechanistic Study Using CRyPTIC Data

Rifampicin (RIF) resistance is used as a proxy for multidrug-resistant tuberculosis, but whether resistant Mycobacterium tuberculosis isolates lacking rpoC / rpoA compensation form an identifiable subset has rarely been tested with open genotype–phenotype data. Reanalyzing Comprehensive Resistance Prediction for Tuberculosis: an International Consortium data, we corrected three data-preparation hazards: conflation of RIF with the related drug rifabutin; isolates lacking a mutation record treated as confirmed wild-type; and a cluster of biologically implausible per-gene mutation counts, which were winsorized. After correction, only 239 isolates (0.53% of the RIF-phenotyped pool) had both a valid phenotype and mutation data, a subset that may not be randomly selected by lineage or geography; however, its resistance rate (30.1%) closely matched that of the wider population (30.3%; p = 0.95). Presence of rpoB was associated with resistance (odds ratio [OR] = 12.90, 95% confidence interval [CI]: 3.89–42.75), and the presence of compensatory rpoC or rpoA mutation was even more strongly associated (OR = 8.28, 95% CI: 4.06–16.88). A logistic-regression classifier reached an area under the curve of 0.75 (95% CI: 0.61–0.89). Eight resistant isolates carried rpoB without compensation and are nominated as candidates for future validation, not a validated finding. The scale of the corrections needed, a 24.6% drug-code misassignment and a genotype file covering 1.3% of phenotyped isolates, shows why reanalyses of public resistance datasets need provenance checks.

Authors

Institutions

Publication Details

Journal
OMICS A Journal of Integrative Biology
Published
2026-11-18
DOI
https://doi.org/10.1177/15578100261508662
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Exploiting RNA-Polymerase Fitness Costs in Rifampicin-Resistant Mycobacterium tuberculosis : A Real-World Genotype–Phenotype Mechanistic Study Using CRyPTIC Data

Amit Kumar Mohapatra, K. Vijayakumar, Sivaramakrishnan Ramachandiran, Aachal Lonhare et al.
OMICS A Journal of Integrative Biology
Tuberculosis Research and Epidemiology
article

Exploiting RNA-Polymerase Fitness Costs in Rifampicin-Resistant Mycobacterium tuberculosis : A Real-World Genotype–Phenotype Mechanistic Study Using CRyPTIC Data

Amit Kumar Mohapatra, K. Vijayakumar, Sivaramakrishnan Ramachandiran, Aachal Lonhare, Rajendra Kumar Behera, Subhrasmita Pradhan, Baranika Gunasekaran, Tejasri Lokaiah, M.D. Abdul Sattar, Srivalli Eloore, Rinu Dash
article en

Abstract

Rifampicin (RIF) resistance is used as a proxy for multidrug-resistant tuberculosis, but whether resistant Mycobacterium tuberculosis isolates lacking rpoC / rpoA compensation form an identifiable subset has rarely been tested with open genotype–phenotype data. Reanalyzing Comprehensive Resistance Prediction for Tuberculosis: an International Consortium data, we corrected three data-preparation hazards: conflation of RIF with the related drug rifabutin; isolates lacking a mutation record treated as confirmed wild-type; and a cluster of biologically implausible per-gene mutation counts, which were winsorized. After correction, only 239 isolates (0.53% of the RIF-phenotyped pool) had both a valid phenotype and mutation data, a subset that may not be randomly selected by lineage or geography; however, its resistance rate (30.1%) closely matched that of the wider population (30.3%; p = 0.95). Presence of rpoB was associated with resistance (odds ratio [OR] = 12.90, 95% confidence interval [CI]: 3.89–42.75), and the presence of compensatory rpoC or rpoA mutation was even more strongly associated (OR = 8.28, 95% CI: 4.06–16.88). A logistic-regression classifier reached an area under the curve of 0.75 (95% CI: 0.61–0.89). Eight resistant isolates carried rpoB without compensation and are nominated as candidates for future validation, not a validated finding. The scale of the corrections needed, a 24.6% drug-code misassignment and a genotype file covering 1.3% of phenotyped isolates, shows why reanalyses of public resistance datasets need provenance checks.

OMICS A Journal of Integrative Biology
Sambalpur University (IN), Siksha O Anusandhan University (IN), VRR Diagnostic Services (India) (IN), Institute of Medical Sciences and Sum Hospital (IN), Dhanalakshmi Srinivasan University (IN), Rungta College (IN)
Tuberculosis Research and Epidemiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon